Soligenix, Inc. (SNGX) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Soligenix, Inc. (SNGX) Bundle
Streamline your analysis and boost precision with our (SNGX) DCF Calculator! With real data from Soligenix, Inc. and customizable assumptions, this tool empowers you to forecast, evaluate, and assess (SNGX) just like a seasoned investor.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.6 | 2.4 | .8 | .9 | .8 | .6 | .4 | .3 | .2 | .2 |
Revenue Growth, % | 0 | -49.04 | -65.07 | 15.12 | -11.55 | -27.63 | -27.63 | -27.63 | -27.63 | -27.63 |
EBITDA | -9.4 | -18.2 | -12.2 | -14.1 | -7.9 | -.6 | -.4 | -.3 | -.2 | -.2 |
EBITDA, % | -202.06 | -772.47 | -1483.49 | -1486.56 | -935.58 | -100 | -100 | -100 | -100 | -100 |
Depreciation | .2 | .2 | .2 | .1 | .0 | .1 | .0 | .0 | .0 | .0 |
Depreciation, % | 3.84 | 8.18 | 18.25 | 14.47 | 0.78083 | 9.1 | 9.1 | 9.1 | 9.1 | 9.1 |
EBIT | -9.5 | -18.4 | -12.4 | -14.2 | -7.9 | -.6 | -.4 | -.3 | -.2 | -.2 |
EBIT, % | -205.89 | -780.66 | -1501.74 | -1501.02 | -936.36 | -100 | -100 | -100 | -100 | -100 |
Total Cash | 5.4 | 18.7 | 26.0 | 13.4 | 8.4 | .6 | .4 | .3 | .2 | .2 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 1.5 | .6 | .2 | .2 | .2 | .2 | .1 | .1 | .1 | .0 |
Account Receivables, % | 31.6 | 23.94 | 29.45 | 23.11 | 23.25 | 26.27 | 26.27 | 26.27 | 26.27 | 26.27 |
Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 0.000043197328 | 0 | 0 | 0.000105383961 | 0 | 0.000029716258 | 0.000029716258 | 0.000029716258 | 0.000029716258 | 0.000029716258 |
Accounts Payable | 2.7 | 2.1 | 2.9 | 3.9 | 1.1 | .5 | .4 | .3 | .2 | .1 |
Accounts Payable, % | 59.08 | 90.27 | 354.93 | 407.39 | 132.39 | 89.87 | 89.87 | 89.87 | 89.87 | 89.87 |
Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | -0.65247 | -0.30291 | -1.43 | -1.38 | -0.000119138533 | -0.75269 | -0.75269 | -0.75269 | -0.75269 | -0.75269 |
Tax Rate, % | 22.35 | 22.35 | 22.35 | 22.35 | 22.35 | 22.35 | 22.35 | 22.35 | 22.35 | 22.35 |
EBITAT | -8.9 | -17.6 | -11.6 | -13.1 | -6.1 | -.6 | -.4 | -.3 | -.2 | -.2 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -7.5 | -17.1 | -10.3 | -12.1 | -8.8 | -1.0 | -.5 | -.3 | -.2 | -.2 |
WACC, % | 6.75 | 6.8 | 6.74 | 6.7 | 6.24 | 6.65 | 6.65 | 6.65 | 6.65 | 6.65 |
PV UFCF | ||||||||||
SUM PV UFCF | -2.0 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | -4 | |||||||||
Present Terminal Value | -3 | |||||||||
Enterprise Value | -5 | |||||||||
Net Debt | -5 | |||||||||
Equity Value | 0 | |||||||||
Diluted Shares Outstanding, MM | 0 | |||||||||
Equity Value Per Share | 0.32 |
What You Will Get
- Comprehensive SNGX Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust discount rates, tax assumptions, revenue growth, and capital investments.
- Dynamic Calculations: Intrinsic value and net present value are computed in real-time.
- Scenario Testing: Explore various scenarios to assess Soligenix’s future potential.
- User-Friendly Interface: Designed for industry experts while remaining approachable for newcomers.
Key Features
- 🔍 Real-Life SNGX Financials: Pre-filled historical and projected data for Soligenix, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Soligenix’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Soligenix’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download: Obtain the comprehensive Excel file featuring Soligenix, Inc. (SNGX) financial data.
- Customize: Tailor your forecasts, including revenue growth, EBITDA %, and WACC.
- Update Automatically: Watch as intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various projections and instantly compare the results.
- Make Decisions: Leverage the valuation outcomes to inform your investment strategy.
Why Choose This Calculator for Soligenix, Inc. (SNGX)?
- Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for Soligenix, Inc. (SNGX).
- Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios for Soligenix, Inc. (SNGX).
- Detailed Insights: Automatically computes Soligenix, Inc. (SNGX)'s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide a solid foundation for analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on Soligenix, Inc. (SNGX).
Who Should Use Soligenix, Inc. (SNGX)?
- Investors: Gain insights into innovative biopharmaceutical solutions and make informed investment choices.
- Healthcare Analysts: Utilize comprehensive data to evaluate the potential of Soligenix's product pipeline.
- Consultants: Tailor presentations and reports on Soligenix's market strategies and clinical developments.
- Biotech Enthusiasts: Enhance your knowledge of the biopharmaceutical industry through Soligenix's advancements.
- Educators and Students: Leverage real-world case studies of Soligenix in academic discussions on biotechnology and pharmaceuticals.
What the Template Contains
- Pre-Filled DCF Model: Soligenix’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Soligenix’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.